Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Vigil Neuroscience, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −11 vs. Q1 2022
- Shares held
- 17.3M
- −515.0K (−2.9%) vs. Q1 2022
- Total value
- $44.6M
- −$80.5M (−64.4%) vs. Q1 2022
- New holders
- 6
- 6 more added
- Sold out
- 17
- 13 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 2 | $4.55K |
| Q2 2025 | 78 | $265.8M |
| Q1 2025 | 50 | $44.5M |
| Q4 2024 | 51 | $38.4M |
| Q3 2024 | 52 | $94.2M |
| Q2 2024 | 58 | $104.5M |
| Q1 2024 | 54 | $90.5M |
| Q4 2023 | 46 | $84.4M |
| Q3 2023 | 45 | $137.7M |
| Q2 2023 | 47 | $242.1M |
| Q1 2023 | 41 | $245.4M |
| Q4 2022 | 37 | $312.3M |
| Q3 2022 | 33 | $222.7M |
| Q2 2022 | 35 | $44.6M |
| Q1 2022 | 47 | $125.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Vigil Neuroscience, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $15.1M | 2.52% | 00.0% | Unchanged |
| Northpond Ventures, LLC | 4,214,498 | $10.9M | 10.36% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,165,036 | $5.47M | 0.01% | +2,397+0.1% | Added |
| Artal Group S.A. | 1,121,191 | $2.89M | 0.16% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 616,786 | $1.59M | 0.12% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $1.45M | 0.73% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 471,958 | $1.22M | 0.04% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 411,191 | $1.06M | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 354,208 | $914.0K | 0.00% | −30,990−8.0% | Reduced |
| Deep Track Capital, LP | 308,393 | $796.0K | 0.06% | −80,748−20.8% | Reduced |
| Harvard Management Co Inc | 289,460 | $747.0K | 0.09% | 00.0% | Unchanged |
| Logos Global Management LP | 205,595 | $530.0K | 0.10% | 00.0% | Unchanged |
| Laurion Capital Management LP | 130,200 | $336.0K | 0.01% | +130,200 | New |
| BlackRock Inc. | 104,223 | $269.0K | 0.00% | −199,466−65.7% | Reduced |
| Barclays PLC | 101,681 | $262.0K | 0.00% | −1,092−1.1% | Reduced |
| DAFNA Capital Management LLC | 99,754 | $257.0K | 0.07% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 73,077 | $189.0K | 0.00% | −762−1.0% | Reduced |
| Citigroup Inc | 65,063 | $168.0K | 0.00% | +969+1.5% | Added |
| Geode Capital Management, LLC | 59,645 | $153.0K | 0.00% | −37,435−38.6% | Reduced |
| Renaissance Technologies LLC | 37,488 | $97.0K | 0.00% | +17,447+87.1% | Added |
| LMR Partners LLP | 25,337 | $65.0K | 0.00% | −2,305−8.3% | Reduced |
| Adage Capital Partners GP, L.L.C. | 22,269 | $57.0K | 0.00% | +22,269 | New |
| State Street Corp | 18,374 | $47.0K | 0.00% | −36,105−66.3% | Reduced |
| Northern Trust Corp | 12,082 | $31.0K | 0.00% | −44,601−78.7% | Reduced |
| Point72 Hong Kong Ltd | 12,139 | $31.0K | 0.00% | −528−4.2% | Reduced |
| Cannell Capital LLC | 3,636 | $9.00K | 0.00% | +3,636 | New |
| Morgan Stanley | 3,338 | $7.00K | 0.00% | +2,462+281.1% | Added |
| UBS Group AG | 2,448 | $6.00K | 0.00% | +1,528+166.1% | Added |
| Cubist Systematic Strategies, LLC | 1,118 | $3.00K | 0.00% | +118+11.8% | Added |
| JPMorgan Chase & Co | 214 | $1.00K | 0.00% | −2,934−93.2% | Reduced |
| New York State Common Retirement Fund | 59 | $0 | 0.00% | −8,441−99.3% | Reduced |
| Wells Fargo & Company | 47 | $0 | 0.00% | −1,418−96.8% | Reduced |
| FMR LLC | 40 | $0 | 0.00% | +40 | New |
| Credit Suisse AG | 4 | $0 | 0.00% | +4 | New |
| PEAK6 Investments LLC | 14,337 | – | – | +14,337 | New |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −86,193−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| Davidson Kempner Capital Management LP | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −19,930−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −19,198−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −13,341−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −3,747−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −3,332−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −2,795−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −2,451−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,773−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −1,519−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −1,600−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,037−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −634−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |